Search Records

This document outlines the recommended goals, objectives, and activities for surveillance of human infection with COVID-19 in Canada. These guidelines are based on current available scientific evidence and expert opinion and are subject to change as new information becomes available.

Organizations, community health workers and volunteers play an important role in helping prevent the spread of COVID-19 among those who experience homelessness. It is important that these service providers plan ahead and take precautions in their environments/workplaces, based on public health...

Canadian public health guidance related to COVID-19 has been changing as the evidence base and our understanding of COVID-19 is rapidly evolving. We are continually looking at the evidence as it is being produced and working with our partners across the country and around the world to learn more.

This document provides recommendations and guidance for re-opening approaches that can be tailored to jurisdictions across the country. It draws on and supports the First Ministers Statement on a shared public health approach to support restarting the economy, and elaborates further advice on...

Workplaces/businesses can implement key measures to limit the spread of the virus in their settings. Workplaces/ businesses are heterogeneous; therefore, the Public Health Agency of Canada recommends that employers and business owners conduct a risk assessment to determine the most appropriate...

While diseases can make anyone sick, some Canadians are more at risk of developing severe complications from an illness due to underlying medical conditions and age. If you are at risk for complications, you can take action to reduce your risk of getting sick from COVID-19.

The purpose of this document is to provide planning guidance for the delivery of health care in Canada during the COVID-19 pandemic, which is expected to result in a prolonged period of increased demand on the health care system.

COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.

Decisions made about COVID-19 vaccines will follow processes established for reviews under the modified requirements for COVID-19 drugs. Health Canada will start rolling reviews to build towards a complete dossier for each vaccine. The dossier will include data to support the safety, efficacy and...

The guidance document concerning amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19 indicates that the plain language labelling requirements for mock-up labels and a brand name assessment package do not apply (C.08.002(2)(j.1) and C.08.002(2)(o)). Although not...